Search

everythinglearnresearchcommunity

for

Search:↓

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Thermo-responsive polymers in nanoparticles enable targeted drug delivery and advanced therapies by releasing drugs at specific temperatures.

Surgical debridement and targeted therapies can effectively heal chronic wounds in KID syndrome.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

Compound 7p shows strong potential as an anticancer agent.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Non-surgical procedures can help reduce wrinkles and stimulate skin repair by understanding skin aging at the molecular level.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Multitarget drugs are needed to better treat complex diseases.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

The conventional extraction method with 50% ethanol was the most effective for antioxidant activity.

Dang Gui may help treat immune-related diseases by boosting and regulating the immune system.

Microextraction techniques improve hormone testing while being environmentally friendly.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.